Structure-function relations of heparin-mimetic sulfated xylan oligosaccharides: Inhibition of human immunodeficiency virus-1 infectivity in vitro

Glycoconjugate Journal

Volumn 15, Issue 7, 1998, Pages 697-712

  Stone, Audrey Larack ^a   Melton, Derek J ^a   Lewis, Marc S ^b  

^a EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH AND HUMAN DEVELOPMENT   (United States)

^b NATIONAL INSTITUTES OF HEALTH   (United States)

Author keywords

anti HIV 1 capacity of components of sulfated xylan; Heparin mimetic oligosaccharides; Mass of sulfated oligosaccharides by Equilibrium ultracentrifugation

Indexed keywords

ANTIVIRUS AGENT; HEPARIN; OLIGOSACCHARIDE; XYLAN;

ABSORPTION SPECTROSCOPY; ANTIVIRAL ACTIVITY; ARTICLE; CONTROLLED STUDY; DRUG SYNTHESIS; HUMAN IMMUNODEFICIENCY VIRUS 1; MOLECULAR WEIGHT; NONHUMAN; PRIORITY JOURNAL; STRUCTURE ACTIVITY RELATION; SULFATION; ULTRACENTRIFUGATION;

ANTI-HIV AGENTS; CARBOHYDRATE SEQUENCE; CD4-POSITIVE T-LYMPHOCYTES; CELL FUSION; GIANT CELLS; HEPARIN; HIV-1; HUMANS; MICROBIAL SENSITIVITY TESTS; MODELS, MOLECULAR; MOLECULAR MIMICRY; MOLECULAR SEQUENCE DATA; MOLECULAR WEIGHT; REFERENCE STANDARDS; STRUCTURE-ACTIVITY RELATIONSHIP; SULFATES; VIRULENCE; XYLANS;

HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1; MAMMALIA; RNA VIRUSES;

EID: 15644374744     PISSN: 02820080     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1006940632184     Document Type: Article

References (76)

1. Silbert JE (1967) J Biol Chem 242: 5146-52.
2. Lindahl U, Hook M, Backstrom G, Jacobsson I, Reisenfeld J, Malstrom A, Roden L, Feingold DS (1977) Fed Proceedings 36: 19-24.
3. Leder IG (1980) Biochem Biophys Res Commun (1980) 94: 1183-9.
4. Bourin M-C, Lindahl U (1993) Biochem J 289: 313-30.
5. Lam LH, Silbert JE, Rosenberg RD (1976) Biochem Biophys Res Commun 69: 570-7.
6. Rosenberg RD (1977) Fed Proceedings 36: 10-17.
7. Rosenberg RD, Jordan RE, Favreau LV, Lam LH (1979) Biochem Biophys Res Commun 86: 1319-24.
8. Oosta GA, Gardner WT, Beeler D, Rosenberg RD (1981) Proc Natl Acad Sci USA 78: 829-33.
9. Rosenberg RD, Bauer KA, Marcum JA (1986) Rev of Hematology 2: 351-416.
10. Savion N, Vlodavsky I, Fuks Z (1984) J Cell Physiol 118: 169-78.
11. Herbert JM (1991) Biochim Biophys Acta 1091: 432-41.
12. Yayon A, Klagsbrun M, Esco J, Leder P, Ornitz DM (1991) Cell 64: 841-8.
13. Walker A, Turnbull JE, Gallagher JT (1994) J Biol Chem 269: 931-5.
14. Sasaki S, Suchi T (1967) Nature 216: 1013-14.
15. Brenan M, Parish CR (1986) Eur J Immunol 16: 423-30.
16. Bradbury MG, Parish CR (1991) Immunol 72: 231-8.
17. Caughey B, Brown K, Raymond GJ, Katzenstein GE, Thresher W (1994) J Virol 68: 2135-41.
18. Bagasra O, Lischner HW (1988) J Infec Dis 158: 1084-7.
19. Baba M, Nakajima M, Schols D, Pauwels R, Balzarini J, De Clercq E (1988) Antiviral Res 9: 335-43.
20. Ueno R, Kuno S (1987) Lancet 1: 1379.
21. Baba M, Pauwels R, Balzarini J, Arnot J, Desmyter J, De Clercq E (1988) Proc Natl Acad Sci USA 85: 6132-6.
22. Coombe DR, Harrop HA, Watton J, Mulloy B, Barrowcliffe TW, Rider CC (1995) AIDS Res and Hum Retroviruses 11: 1393-6.
23. Witvreuw M, Desmyter J, De Clercq E (1994) Antiviral Chem & Chemother 5: 345-59 (Review).
24. Lederman S, Gulick R, Chess E (1989) J. Immunol 143: 1149-54.
25. McClure MO, Moore JP, Blanc DF, Scotting P, Cook JMW, Keynes RJ, Weber JN, Davies D, Weiss RA (1992) Aids Res & Hum Retroviruses 8: 19-26.
26. Baba M, Schols D, Pauwels R, Nakashima H, De Clercq E (1990) J Acquired Immune Defi Dis 3: 493-9.
27. Zugmaier G, Lippman ME, Wellstein A (1992) J Natl Cancer Inst 84: 1716-24.
28. Meri S, Pangburn MK (1994) Biochem Biophys Res Comm, 198: 52-9.
29. Koistinen V (1993) Mol Immunol 30: 113-18.
30. Stone AL (1985) Arch Biochem Biophys 236: 342-53.
31. Stscherbina D, Philipp B (1991) Acta Polym 42: 345-51 (Review).
32. Pienta KJ, Murphy BC, Issacs JT, Coffey DS (1992) Prostate 20: 233-41.
33. Caughey B, Raymond GJ (1993) J Virol 67: 643-50.
34. Ladogana A, Casaccia P, Ingrosso L, Cibati M, Salvatore M, Xi YG, Masullo C, Pocchiari M (1992) J Gen Virol 73: 661-5.
35. Baba M, De Clercq E, Schols D, Pauwels R, Snoeck R, Van Boeckel C, Vandedom G, Kraaileveld N, Hobbelen P, Ottenheim H, Den Hollander F (1990) J Infec Dis 161: 208-13.
36. Abrams I, Kuno S, Wong R, Jeffords K, Nash M, Molaghan JB, Gortner R, Ueno R (1989) Ann Inter Med 10: 183-8.
37. Pluda JM, Shay LE, Foli A, Tannenbaum S, Cohen PJ, Goldspeil BR, Adamo D, Cooper MR, Broder S, Yarchoan R (1993) J Natl Cancer Inst 85: 1585-92.
38. Swain SM, Parker B, Wellstein A, Lippman ME, Steakley C, DeLap R (1995) Invest New Drugs 13: 55-62.
39. Marshall JL, Hawkins MJ (1995) Breast Cancer Res & Treatment 36: 253-61.
40. Stone AL, Melton DJ (1991) Glycoconjugate J 8: 175.
41. Stone AL, Spitzin SV, Melton DJ (1992) Glycobiology 2: 468.
42. Raveux R, Gros P, Briot M (1965) Bull Soc Chim Fr 33: 2744-9.
43. Aspinall GO, Hirst EL, Mahomed J (1954) J Chem Soc 1734-41.
44. Constantopoulos G, Dekaban AS, Carroll WR (1969) Anal Biochem 31: 59-70.
45. Stone AL, Childers LG, Bradley DF (1963) Biopolymers 1: 111-31.
46. Stone AL, Bradley DF (1967) Biochim Biophys Acta 148: 172-92.
47. Stone AL, Szu SC (1988) J Clin Microbiol 26: 719-25.
48. Stone AL (1981) In Chemistry and Biology of Heparin (Lunbad RL, Brown WV, Mann KG, Roberts HR, eds) pp 143-56, New York: Elsevier/North Holland.
49. Weislow OS, Kiser R, Fine DL, Bader J, Shoemaker RH, Boyd MR (1989) J Natl Cancer Inst 81: 577-86.
50. Nara PL (1990) In Techniques in HIV Research, Aldovini A, Walker B, eds, pp 77-86, New York: Stockholm Press.
51. Avigad G (1977) J Chromatog 139: 343-7.
52. Lewis MS (1992) In Analytical Ultracentrifugation in Biochemistry and Polymer Science, Harding SE, Rowe AJ, Horton JC, eds, pp 126-37, London: Royal Society of Chemistry.
53. Zamyatnin AA (1984) An Rev Biophys Bioeng 13: 145-65.
54. Durchshlag H (1986) In Thermodynamic Data for Biochemistry and Biotechnology, Hinz H-J, ed, pp. 45-128, New York: Springer-Verlag.
55. Lasker, SE (1965) Some properties of fractionated heparin: Dissertation, ed. University Microfilms, Inc. (Ann Arbor, MI).
56. Jordan RE, Favreau LV, Braswell EH, Rosenberg RD (1982) J Biol Chem 257: 400-6.
57. Knott GD (1979) Comput Programs Biomed 10: 271-80.
58. Williams JW, Van Holde KF, Baldwin RL, Fujita H (1958) Chem Rev 58: 715-806.
59. Hoare DG, Koshland DE (1967) J Biol Chem 242: 2447-53.
60. Horikawa R, Tanimura T (1982) Anal Lett 15: 1629-42.
61. Bystricky S, Szu SC (1994) Biophys Chemistry 50: 1-7.
62. Stone AL (1967) Biochim Biophys Acta 148: 193-206.
63. Stone AL, Spitzin SV, Melton DJ (1993) Glycobiology 3: 520.
64. Stone AL (1964) Biopolymers 2: 315-325.
65. Atkins TE (1977) Fed Proceedings 36: 78-83.
66. Bitter T, Muir HM (1962) Anal Biochem 4: 330-4.
67. Barzue T, Level M, Petitou M, Lormeau J-C, Choay J, Schols D, Baba M, Pauwels R, Witvrouw M, De Clerq E (1993) J Med Chem 36: 3546-55.
68. Lopalco L, Ciccomascolo F, Lanza P, Zoppetti G, Caramazza I, Leoni F, Beretta A, Siccardi AG (1994) AIDS Res & Hu Retroviruses 10: 787-93.
69. Nara P, Garrity RR, Goudsmit J (1991) FASEB J 5: 2437-55.
70. Faham S, Hileman RE, Fromm JR, Linhardt RJ, Rees DC (1996) Science 271: 1116-20.
71. Feng Y, Broder C, Kennedy PE, Berger EA (1996) Science 272: 872-7.
72. Alkhatlb G, Combadiere C, Broder C, Feng Y, Kennedy PE, Murphy PM, Berger EA (1996) Science 272: 1955-8.
73. Hoffmann RA, Leeflang BR, deBarse MMJ, Amerling JP, Vliegenthart (1991) Carbohydr Res 221: 63-81.
74. Wel S, Ghosh S, Taylor ME, Johnson VA, Emini EA, Deutsch P, Lifson JD, Bonhoeffer S, Nowak MA, Hahn BH, Saag MS, Shaw GM (1995) Nature 373: 117-22.
75. Ho DD, Neuman AU, Perelson AS, Chen W, Leonard JM, Markowitz M (1995) Nature 373: 123-6.
76. Stone AL, Melton DJ, Horne MK (1996) Glycobiology 6: 773.